References
- Vardiman JW, Bennett JM, Bain BJ, et al. Atypical chronic myeloid leukaemia, BCR-ABL1 negative. In: Swerdlow SH, Campo E, Lee Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008:80–81.
- Meggendorfer M, Bacher U, Alpermann T, et al. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013;27:1852–1860.
- Piazza R, Valletta S, Winkelmann N, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 2013; 45:18–24.
- Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013;368:1781–1790.
- Pardanani A, Lasho TL, Laborde RR, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013;27:1870–1873.
- Shaffer LG, Slovak ML, Campbell LJ, editors. ISCN 2009: an international system for human cytogenetic nomenclature. Basel: Karger; 2009.
- Lichter P, Tang Chang CJ, Call K, et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990;247:64–69.
- Breccia M, Biondo F, Latagliata R, et al. Identification of risk factors in atypical chronic myeloid leukemia. Haematologica 2006; 91:1566–1568.
- Hernandez JM, del Cañizo MC, Cuneo A, et al. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000;11:441–444.
- Gotlib J, Maxson JE, George TI, et al. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood 2013;122:1707–1711.
- Singbrant S, Wall M, Moody J, et al. The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease. Haematologica 2014;99:647–655.
- Lizcova L, Zemanova Z, Malinova E, et al. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome. Cancer Genet Cytogenet 2010;201:52–56.
- Beeharry N, Rattner JB, Caviston JP, et al. Centromere fragmentation is a common mitotic defect of S and G2 checkpoint override. Cell Cycle 2013;12:1588–1597.